Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
Details : Theramex has entered into an agreement with Enzene Biosciences to develop, register and commercialise a biosimilar drug of Roche’s reference medicine RoActemra® (Tocilizumab). Tocilizumab will be avail...
Product Name : Undisclosed
Product Type : Large molecule
Upfront Cash : Undisclosed
December 23, 2021
Lead Product(s) : Tocilizumab,Methotrexate
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Theramex
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?